| | Cell source | Cytokine family | Leukocyte phenotype | Detected in plaque | Primary signaling |
| Proatherogenic | | | | | | IL-1 | M, L, EC, and SMC | IL-1 | − | + | p38/NF-B | IL-6 | M, L, EC, and SMC | IL-6 | − | + | JAK1/STAT3 | IL-8 | M, L, EC, and SMC | IL-8 | − | + | GPCR/NF-B | IL-12 | M, L | IL-6 | Th1 | + | JAK2/STAT3 | IL-18 | M | IL-1 | Th1 | + | p38/NF-B | IFN | M, L, EC, and SMC | IFN | Th1 | + | JAK1/STAT1,2 | TNF | M, L, and SMC | TNF | − | + | p38/NF-B |
| Antiatherogenic | | | | | | IL-10 | M, L | IL-10 | Th2 | + | JAK1/STAT1,3,5 | IL-33 | M, L | IL-1 | Th2 | + | p38/NF-B | TGF | M, L, SMC, and P | TGF | Th2 | + | SMAD2,3 |
| Likely antiatherogenic | | | | | | IL-4 | L | IL-4 | Th2 | + | JAK1/STAT5 | IL-19 | M, L, EC, and SMC | IL-10 | Th2 | − | JAK1/STAT3 |
|
|